Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
Manufactured by
Larissa, Greece
ProGnosis Biotech, headquartered in Greece, is a global diagnostics provider with 11 subsidiaries and distributors in over 90 countries. The company offers a wide range of ELISA kits and lateral flow tests for the detection of mycotoxins, food allergens, antibiotic residues, GMOs, milk adulteration and histamine. It also provides hygiene monitoring solutions, including ATP detection and clinical diagnostics. ProGnosis Biotech also designs and produces proprietary antibodies, hardware and software, including an Android mobile app for instant report sharing.Committed to sustainable practices, it emphasizes green extraction methods and digital traceability, empowering safer food chains and protecting consumer health worldwide.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 1 relevant product
SureScreen Diagnostics Limited
United Kingdom · 4 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 2 relevant products
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 1 relevant product
Hangzhou Lysun Biotechnology Co.,Ltd
China · 2 relevant products
Xiamen Biotime Biotechnology Co., Ltd.
China · 3 relevant products
Biopanda Reagents
United Kingdom · 4 relevant products
FIH Health & Biotech A Foxconn Company
United States · 1 relevant product
Hangzhou AllTest Biotech Co.,Ltd
China · 7 relevant products
MedLevensohn
Brazil · 2 relevant products
69 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 114 closest product alternatives
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specificity for viral antigen identification.
SureScreen Diagnostics Limited · United Kingdom
A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
Rapid molecular detection kit for simultaneous identification of SARS-CoV-2, influenza A, and influenza B viruses. Utilizes isothermal amplification technology for quick diagnostic results.
Hangzhou Lysun Biotechnology Co.,Ltd · China
A rapid self-test kit for detecting antigens of Influenza A, Influenza B, COVID-19, and RSV. Provides quick results for respiratory viral infections.
Xiamen Biotime Biotechnology Co., Ltd. · China
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2 antigen and influenza A/B viruses.
Biopanda Reagents · United Kingdom
An immunochromatographic assay for qualitative detection of SARS-CoV-2 nucleocapsid protein and Influenza A+B virus antigens in nasal and nasopharyngeal swab samples. It is intended to assist in the diagnosis of SARS-CoV-2 and Influenza A+B infections in conjunction with other tests.
FIH Health & Biotech A Foxconn Company · United States
A rapid diagnostic test device for point-of-care detection of COVID-19 and influenza pathogens. The tester provides quick results for respiratory infection screening in clinical and non-clinical settings.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid diagnostic test that simultaneously detects COVID-19 and Influenza A+B antigens using a nasopharyngeal swab sample.
MedLevensohn · Brazil
A rapid diagnostic combo test for simultaneous detection of COVID-19 and Influenza H1N1 antigens.
AccuBioTech Co., Ltd. · China
A rapid immunochromatographic test for the qualitative detection of SARS-CoV-2 antigens, enabling quick screening and diagnosis in clinical and point-of-care settings.
POCBio (Nexlab Co., Ltd.) · China
A multiplex rapid diagnostic test designed to differentiate between COVID-19, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV) infections. This test addresses the overlapping symptoms of these respiratory infections and enables rapid differential diagnosis for clinical decision-making.
102 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products